Daniela Toneatto

3.3k total citations
50 papers, 2.4k citations indexed

About

Daniela Toneatto is a scholar working on Epidemiology, Microbiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniela Toneatto has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 47 papers in Microbiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniela Toneatto's work include Bacterial Infections and Vaccines (47 papers), Pneumonia and Respiratory Infections (45 papers) and Influenza Virus Research Studies (18 papers). Daniela Toneatto is often cited by papers focused on Bacterial Infections and Vaccines (47 papers), Pneumonia and Respiratory Infections (45 papers) and Influenza Virus Research Studies (18 papers). Daniela Toneatto collaborates with scholars based in Italy, United Kingdom and United States. Daniela Toneatto's co-authors include Peter Dull, Ellen Ypma, Susanna Esposito, Roman Prymula, Matthew D. Snape, Andrew J. Pollard, Alan Kimura, Tessa M. John, Philipp Oster and Igor Kohl and has published in prestigious journals such as The Lancet, JAMA and PEDIATRICS.

In The Last Decade

Daniela Toneatto

49 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniela Toneatto Italy	25	2.0k	2.0k	244	181	181	50	2.4k
Paul Balmer United Kingdom	30	2.0k 1.0×	1.7k 0.8×	387 1.6×	213 1.2×	259 1.4×	91	2.5k
Hanne Nøkleby Norway	19	1.8k 0.9×	1.7k 0.8×	257 1.1×	187 1.0×	179 1.0×	43	2.2k
Jamie Findlow United Kingdom	36	3.2k 1.5×	3.2k 1.6×	332 1.4×	202 1.1×	234 1.3×	93	3.6k
Jay Lucidarme United Kingdom	24	1.8k 0.9×	1.9k 0.9×	103 0.4×	117 0.6×	160 0.9×	71	2.1k
Keith Cartwright United Kingdom	26	2.1k 1.1×	2.0k 1.0×	216 0.9×	193 1.1×	166 0.9×	46	2.5k
Ellen Ypma Italy	15	1.5k 0.7×	1.0k 0.5×	279 1.1×	254 1.4×	98 0.5×	23	1.7k
Jane O’Hallahan New Zealand	19	1.2k 0.6×	1.3k 0.6×	152 0.6×	128 0.7×	117 0.6×	24	1.5k
Jenny MacLennan United Kingdom	16	1.1k 0.5×	1.1k 0.5×	207 0.8×	197 1.1×	95 0.5×	30	1.4k
Tessa M. John United Kingdom	19	1.2k 0.6×	1.1k 0.6×	162 0.7×	185 1.0×	121 0.7×	34	1.5k

Countries citing papers authored by Daniela Toneatto

Since Specialization

Citations

This map shows the geographic impact of Daniela Toneatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Toneatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Toneatto more than expected).

Fields of papers citing papers by Daniela Toneatto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Toneatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Toneatto. The network helps show where Daniela Toneatto may publish in the future.

Co-authorship network of co-authors of Daniela Toneatto

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Toneatto. A scholar is included among the top collaborators of Daniela Toneatto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Toneatto. Daniela Toneatto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borrow, Ray, Daniela Toneatto, Stefania Bambini, et al.. (2025). Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine. mSphere. 10(4). e0089824–e0089824. 1 indexed citations

Abitbol, Véronique, Federico Martinón‐Torres, Muhamed‐Kheir Taha, et al.. (2024). 4CMenB journey to the 10-year anniversary and beyond. Human Vaccines & Immunotherapeutics. 20(1). 2357924–2357924. 11 indexed citations

Martinón‐Torres, Federico, Terry Nolan, Daniela Toneatto, & Angelika Banzhoff. (2019). Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults. Human Vaccines & Immunotherapeutics. 15(12). 2940–2951. 19 indexed citations

Sáfadi, Marco Aurélio Palazzi, Federico Martinón‐Torres, Lily Yin Weckx, et al.. (2019). Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial. Vaccine. 37(35). 4858–4863. 2 indexed citations

Welsch, Jo Anne, Shelly Senders, Brandon Essink, et al.. (2018). Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study. Vaccine. 36(35). 5309–5317. 23 indexed citations

Martinón‐Torres, Federico, Marco Aurélio Palazzi Sáfadi, Juan Carlos Tejedor Torres, et al.. (2017). Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial. Vaccine. 35(28). 3548–3557. 39 indexed citations

Martinón‐Torres, Federico, Francisco Giménez‐Sánchez, Éva Kovács, et al.. (2017). Antibody persistence and booster responses 24–36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial. Journal of Infection. 76(3). 258–269. 28 indexed citations

Sadarangani, Manish, Mildred A. Iro, Matthew D. Snape, et al.. (2017). Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules. Canadian Medical Association Journal. 189(41). E1276–E1285. 13 indexed citations

Sáfadi, Marco Aurélio Palazzi, Federico Martinón‐Torres, Lily Yin Weckx, et al.. (2017). Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial. Vaccine. 35(16). 2052–2059. 14 indexed citations

10.

Snape, Matthew D., Merryn Voysey, Adam Finn, et al.. (2016). Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age. The Pediatric Infectious Disease Journal. 35(4). e113–e123. 27 indexed citations

11.

Iro, Mildred A., Matthew D. Snape, Merryn Voysey, et al.. (2016). Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial. Vaccine. 35(2). 395–402. 19 indexed citations

12.

Vesikari, Timo, Roman Prymula, Elizabeth Merrall, et al.. (2015). Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children. Vaccine. 33(32). 3850–3858. 17 indexed citations

13.

Seib, Kate L., Maria Scarselli, Maurizio Comanducci, Daniela Toneatto, & Vega Masignani. (2015). Neisseria meningitidisfactor H-binding protein fHbp: a key virulence factor and vaccine antigen. Expert Review of Vaccines. 14(6). 841–859. 58 indexed citations

14.

Perrett, Kirsten P., Jodie McVernon, Peter Richmond, et al.. (2015). Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study. Vaccine. 33(39). 5217–5224. 34 indexed citations

15.

Finn, Adam, Gianni Bona, Susanna Esposito, et al.. (2012). Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules. JAMA. 307. 4 indexed citations

16.

Santolaya, Marı́a Elena, Miguel L. O’Ryan, María Teresa Valenzuela, et al.. (2012). Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. The Lancet. 379(9816). 617–624. 199 indexed citations

17.

Findlow, Jamie, Ray Borrow, Matthew D. Snape, et al.. (2010). Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy. Clinical Infectious Diseases. 51(10). 1127–1137. 226 indexed citations

18.

Snape, Matthew D., Tom Dawson, Philipp Oster, et al.. (2010). Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life. The Pediatric Infectious Disease Journal. 29(11). e71–e79. 159 indexed citations

19.

Esposito, Susanna, Samantha Bosis, Lorenza Pugni, et al.. (2007). Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine. 25(26). 4889–4894. 12 indexed citations

20.

Iorio, Anna Maria, Daniela Francisci, Barbara Camilloni, et al.. (2003). Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. Vaccine. 21(25-26). 3629–3637. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact